ST. PAUL, MN – February 16, 2001 – Hypertension Diagnostics, Inc. (Nasdaq SmallCap: HDII; HDIIW; HDIIU), said today that the company was recently featured in a CEO Interview profile published in The Wall Street Transcript.

In the January 22, 2001 issue of The Wall Street Transcript ("TWST"), a five page interview with Greg H. Guettler, President, and James S. Murphy, Senior Vice President, Finance and Administration and Chief Financial Officer, was published. Using a question and answer format, a wide range of subjects relating to Hypertension Diagnostics were covered including the history and overview of HDI’s business, information about the HDI/PulseWave™ CR-2000 research and CVProfilor^® DO-2020 physician products, the markets and marketing plans for these CardioVascular Profiling Systems, reimbursement regarding tests using the CVProfilor^® DO-2020 System, and future milestones for investors to anticipate. When asked by the TWST interviewer for reasons why potential investors might consider buying HDI stock, Mr. Guettler responded that HDI has a fully developed, patented, scientifically validated and FDA cleared medical technology with a sizeable market opportunity involving payers and consumers all of whom seem to be embracing cardiovascular disease prevention. The CVProfilor^® System is able to address this concern by non-invasively screening patients in doctor’s offices to determine if they have potential underlying vascular disease that might require more specific diagnostic evaluation by their physician.

Forward-looking statements in this press release are made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The Company wishes to caution readers not to place undue reliance on any forward-looking statements and to recognize that the statements are not predictions of actual future results. Actual results could differ materially from those presented and anticipated in the forward-looking statements due to the risks and uncertainties set forth in the Company's 2000 Annual Report on Form 10-KSB under the caption "Risk Factors," as well as others not now anticipated.

Hypertension Diagnostics, HDI/PulseWave™ and CVProfilor^® are trademarks of Hypertension Diagnostics, Inc. All rights reserved.

Contact: Greg H. Guettler, President